SARS-CoV-2 infects cells via its spike protein binding to its surface receptor on target cells
and results in acute symptoms involving especially the lungs known as COVID-19. However …

Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) predominantly
infects the respiratory system, several investigations have shown the involvement of the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19). About 45% of COVID-19 patients experience several symptoms a …

In addition to respiratory complications produced by SARS‐CoV‐2, accumulating evidence
suggests that some neurological symptoms are associated with the disease caused by this …

Neuroinflammation caused by COVID‐19 negatively impacts brain metabolism and function,
while pre‐existing brain pathology may contribute to individuals' vulnerability to the adverse …

Children with the new coronavirus disease 2019 (COVID-19) have milder symptoms and a
better prognosis than adult patients. Several investigations assessed type I, II, and III …

Protein aggregates associated with neurodegenerative diseases have the ability to transmit
to unaffected cells, thereby templating their own aberrant conformation onto soluble …

Human cerebral organoid (CO) is a three-dimensional (3D) cell culture system that
recapitulates the developing human brain. While CO has proved an invaluable tool for …

SARS-CoV-2 infects cells via its spike (S) protein binding to its surface receptor angiotensin
converting enzyme 2 (ACE2) on target cells and results in acute symptoms involving …

Coronavirus Disease 2019 is predominantly a disorder of the respiratory system, but
neurological complications have been recognised since early in the pandemic. The major …